Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

Maarten Criel; Maarten Falter; Jasmien Jaeken; Margaretha Van Kerrebroeck; Isabelle Lefere; Liesbeth Meylaerts; Dieter Mesotten; Margot Vander Laenen; Tom Fivez; Michiel Thomeer; David Ruttens

doi:10.1183/13993003.01201-2020

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?

Eur Respir J. 2020 Jul 30;56(1):2001201. doi: 10.1183/13993003.01201-2020. Print 2020 Jul.

Authors

Affiliations

¹ Dept Pulmonary Medicine, Ziekenhuis Oost Limburg, Genk, Belgium.
² Dept Radiology, Ziekenhuis Oost Limburg, Genk, Belgium.
³ Dept of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
⁴ Dept of Anaesthesiology, Intensive Care, Emergency Medicine and Pain Therapy, Ziekenhuis Oost-Limburg, Genk, Belgium.
⁵ Dept Pulmonary Medicine, Ziekenhuis Oost Limburg, Genk, Belgium [email protected].

Abstract

Insidious venous thromboembolism (VTE) is mainly a problem in ICU-ventilated SARS-CoV-2 patients, while patients in the general ward, treated with thromboprophylaxis (0.5 mg·kg⁻¹), had a low incidence of insidious VTE https://bit.ly/2Yl8jft

Publication types

Letter

MeSH terms

Aged
Betacoronavirus
Body Mass Index
COVID-19
Cohort Studies
Coronavirus Infections / complications*
Critical Care
Female
Humans
Intensive Care Units
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
Respiration, Artificial / adverse effects*
Risk Factors
SARS-CoV-2
Treatment Outcome
Venous Thromboembolism / complications*
Venous Thromboembolism / prevention & control*